GERN

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Geron Corporation

NASDAQ | GERN

1.28

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 15, 2025)

$807.03M

Market Cap

-

P/E Ratio

-0.13

EPS

$4.50

52 Week High

$1.09

52 Week Low

HEALTHCARE

Sector

GERN Chart

Recent Chart
Price Action

GERN Technicals

Tags:

GERN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $76M
Total Revenue $77M
Cost Of Revenue $1.3M
Costof Goods And Services Sold $1.3M
Operating Income -$174M
Selling General And Administrative $146M
Research And Development $104M
Operating Expenses $249M
Investment Income Net -
Net Interest Income $1.1M
Interest Income $20M
Interest Expense $19M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.2M
Income Before Tax -$175M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$175M
Comprehensive Income Net Of Tax -
Ebit -$156M
Ebitda -$155M
Net Income -$175M

Revenue & Profitability

Earnings Performance

GERN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $594M
Total Current Assets $491M
Cash And Cash Equivalents At Carrying Value $79M
Cash And Short Term Investments $79M
Inventory $39M
Current Net Receivables $39M
Total Non Current Assets $103M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $95M
Short Term Investments $328M
Other Current Assets $6.9M
Other Non Current Assets -
Total Liabilities $313M
Total Current Liabilities $88M
Current Accounts Payable $8.6M
Deferred Revenue -
Current Debt -
Short Term Debt $1.9M
Total Non Current Liabilities $225M
Capital Lease Obligations $3.2M
Long Term Debt $118M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $122M
Other Current Liabilities $78M
Other Non Current Liabilities $104M
Total Shareholder Equity $280M
Treasury Stock -
Retained Earnings -$1.8B
Common Stock $606K
Common Stock Shares Outstanding $646M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$219M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.2M
Capital Expenditures $680K
Change In Receivables -
Change In Inventory -$38M
Profit Loss -
Cashflow From Investment -$106M
Cashflow From Financing $334M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$175M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $76M
Total Revenue $77M
Cost Of Revenue $1.3M
Costof Goods And Services Sold $1.3M
Operating Income -$174M
Selling General And Administrative $146M
Research And Development $104M
Operating Expenses $249M
Investment Income Net -
Net Interest Income $1.1M
Interest Income $20M
Interest Expense $19M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.2M
Income Before Tax -$175M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$175M
Comprehensive Income Net Of Tax -
Ebit -$156M
Ebitda -$155M
Net Income -$175M

GERN News

GERN Profile

Geron Corporation Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Geron Corporation is a clinical biopharmaceutical company headquartered in Foster City, California, specializing in the development and commercialization of innovative therapies for myeloid hematologic neoplasms, particularly acalabrutinib and telomerase inhibitors. With a robust pipeline and a commitment to addressing unmet medical needs in this field, Geron aims to transform the treatment landscape for patients with blood cancers. The company is positioned at the forefront of hematology research, leveraging advanced scientific capabilities to deliver novel therapies with the potential for significant clinical impact.

GNPX
+232.67%
$0.84
YYAI
-10.40%
$0.13
VHAI
-20.00%
$0.00
BURU
-17.95%
$0.33
NVDA
-0.11%
$179.83
CGBS
-39.47%
$0.03
TOVX
+92.08%
$0.84
COOT
+173.57%
$2.64
PLUG
-4.93%
$3.85
BITF
+9.84%
$6.47
DFLI
+28.75%
$1.97
NVTS
+20.60%
$15.16
CAN
+8.88%
$1.96
RGTI
+0.39%
$56.34
OMER
+154.14%
$10.42
TLRY
+5.00%
$1.68
DNN
-0.78%
$3.16
LAES
-2.09%
$7.49
AMD
+9.40%
$238.60
RXRX
+6.50%
$5.89
RR
-8.46%
$6.16
INTC
+4.26%
$37.15
ACHR
+0.07%
$13.03
BYND
-12.41%
$0.68
F
+0.94%
$11.76
QBTS
+3.99%
$44.78
QS
+5.74%
$17.85
YDKG
-86.28%
$0.19
TSLA
+1.37%
$435.15
IONZ
+12.06%
$2.88
BAC
+4.37%
$52.28
AXDX
-61.36%
$0.03
BBD
+1.58%
$3.20
ETHD
+6.47%
$3.78
NOK
+3.19%
$5.64
CIFR
+0.67%
$21.03
ADAP
+15.06%
$0.18
PFAI
+139.26%
$4.57
RIG
+5.44%
$3.29
SOFI
+0.57%
$28.03
SMR
+16.71%
$53.44
UUUU
-4.72%
$24.99
MARA
+2.69%
$22.84
BTBT
-1.69%
$4.05
FHN
-9.49%
$20.83
HIMS
+16.17%
$62.76
BTG
+5.99%
$5.66
QSI
+22.32%
$2.63
QUBT
-2.52%
$21.23
APLD
+7.76%
$37.76
CRML
-24.19%
$22.72
AAL
+2.54%
$12.50
SOUN
+2.32%
$21.34
NAK
-4.34%
$2.64
JOBY
-2.81%
$17.60
ONDS
-8.64%
$9.51
PFE
-0.53%
$24.39
IREN
-2.27%
$67.98
DVLT
-4.10%
$2.10
VERI
+53.66%
$8.39
GPUS
-5.02%
$0.38
SLNH
+53.76%
$4.29
WULF
+0.06%
$15.47
AMZN
-0.37%
$215.57
GDXD
-12.00%
$0.66
CLSK
+5.55%
$23.20
TMQ
-20.18%
$8.46
ATCH
+0.99%
$0.40
ABAT
-21.00%
$8.94
UAMY
-21.23%
$13.76
SEED
+51.91%
$2.18
RGTZ
-1.13%
$8.69
RMBL
+60.50%
$3.21
NIO
+0.29%
$6.82
SNAP
-0.12%
$7.91
WWR
-29.02%
$2.47
BMNR
+1.19%
$53.55
ADD
-25.47%
$0.05
VALE
+1.82%
$11.17
GRAB
+0.16%
$5.92
PLTR
-0.06%
$179.62
RF
-1.66%
$24.74
SANA
+33.03%
$5.92
SRM
+53.27%
$10.30
CLF
-0.07%
$13.95
ASST
-3.71%
$0.95
T
-0.22%
$26.07
NEHC
+9.12%
$3.35
NUAI
+9.12%
$3.35
NAKA
+1.29%
$0.79
OKLO
-1.53%
$171.47
KDLY
+1.29%
$0.79
AREC
-26.43%
$5.01
AAPL
+0.63%
$249.34
USAR
-10.29%
$33.68
HI
+18.19%
$31.31
EOSE
+7.65%
$18.28
CGC
+6.26%
$1.44
IONQ
-6.62%
$72.41
RIVN
+2.55%
$13.45
GNPX
+232.67%
$0.84
YYAI
-10.40%
$0.13
VHAI
-20.00%
$0.00
BURU
-17.95%
$0.33
NVDA
-0.11%
$179.83
CGBS
-39.47%
$0.03
TOVX
+92.08%
$0.84
COOT
+173.57%
$2.64
PLUG
-4.93%
$3.85
BITF
+9.84%
$6.47
DFLI
+28.75%
$1.97
NVTS
+20.60%
$15.16
CAN
+8.88%
$1.96
RGTI
+0.39%
$56.34
OMER
+154.14%
$10.42
TLRY
+5.00%
$1.68
DNN
-0.78%
$3.16
LAES
-2.09%
$7.49
AMD
+9.40%
$238.60
RXRX
+6.50%
$5.89
RR
-8.46%
$6.16
INTC
+4.26%
$37.15
ACHR
+0.07%
$13.03
BYND
-12.41%
$0.68
F
+0.94%
$11.76
QBTS
+3.99%
$44.78
QS
+5.74%
$17.85
YDKG
-86.28%
$0.19
TSLA
+1.37%
$435.15
IONZ
+12.06%
$2.88
BAC
+4.37%
$52.28
AXDX
-61.36%
$0.03
BBD
+1.58%
$3.20
ETHD
+6.47%
$3.78
NOK
+3.19%
$5.64
CIFR
+0.67%
$21.03
ADAP
+15.06%
$0.18
PFAI
+139.26%
$4.57
RIG
+5.44%
$3.29
SOFI
+0.57%
$28.03
SMR
+16.71%
$53.44
UUUU
-4.72%
$24.99
MARA
+2.69%
$22.84
BTBT
-1.69%
$4.05
FHN
-9.49%
$20.83
HIMS
+16.17%
$62.76
BTG
+5.99%
$5.66
QSI
+22.32%
$2.63
QUBT
-2.52%
$21.23
APLD
+7.76%
$37.76
CRML
-24.19%
$22.72
AAL
+2.54%
$12.50
SOUN
+2.32%
$21.34
NAK
-4.34%
$2.64
JOBY
-2.81%
$17.60
ONDS
-8.64%
$9.51
PFE
-0.53%
$24.39
IREN
-2.27%
$67.98
DVLT
-4.10%
$2.10
VERI
+53.66%
$8.39
GPUS
-5.02%
$0.38
SLNH
+53.76%
$4.29
WULF
+0.06%
$15.47
AMZN
-0.37%
$215.57
GDXD
-12.00%
$0.66
CLSK
+5.55%
$23.20
TMQ
-20.18%
$8.46
ATCH
+0.99%
$0.40
ABAT
-21.00%
$8.94
UAMY
-21.23%
$13.76
SEED
+51.91%
$2.18
RGTZ
-1.13%
$8.69
RMBL
+60.50%
$3.21
NIO
+0.29%
$6.82
SNAP
-0.12%
$7.91
WWR
-29.02%
$2.47
BMNR
+1.19%
$53.55
ADD
-25.47%
$0.05
VALE
+1.82%
$11.17
GRAB
+0.16%
$5.92
PLTR
-0.06%
$179.62
RF
-1.66%
$24.74
SANA
+33.03%
$5.92
SRM
+53.27%
$10.30
CLF
-0.07%
$13.95
ASST
-3.71%
$0.95
T
-0.22%
$26.07
NEHC
+9.12%
$3.35
NUAI
+9.12%
$3.35
NAKA
+1.29%
$0.79
OKLO
-1.53%
$171.47
KDLY
+1.29%
$0.79
AREC
-26.43%
$5.01
AAPL
+0.63%
$249.34
USAR
-10.29%
$33.68
HI
+18.19%
$31.31
EOSE
+7.65%
$18.28
CGC
+6.26%
$1.44
IONQ
-6.62%
$72.41
RIVN
+2.55%
$13.45
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.